MoonLake Immunotherapeutics
MLTX15.510USD
+0.740+5.01%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
988.06M시가총액
손실P/E TTM
자세한 내용은 MoonLake Immunotherapeutics 회사
MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
MoonLake Immunotherapeutics 정보
종목 코드 MLTX
회사 이름MoonLake Immunotherapeutics
상장일Oct 20, 2020
CEOSantos Da Silva (Jorge)
직원 수100
유형Ordinary Share
회계 연도 종료Oct 20
주소Dorfstrasse 29
도시ZUG
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Switzerland
우편 번호6300
전화41415108022
웹사이트https://moonlaketx.com/
종목 코드 MLTX
상장일Oct 20, 2020
CEOSantos Da Silva (Jorge)
MoonLake Immunotherapeutics의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
2.96M
-167519.00%
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
1.28M
+354296.00%
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Spike N. Loy, J.D.
Mr. Spike N. Loy, J.D.
Independent Director
Independent Director
--
--
Ms. Catherine Moukheibir
Ms. Catherine Moukheibir
Independent Director
Independent Director
--
--
Dr. Ramnik Xavier
Dr. Ramnik Xavier
Independent Director
Independent Director
--
--
Dr. Atif Khan
Dr. Atif Khan
Director - Strategic Planning and Projects
Director - Strategic Planning and Projects
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
2.96M
-167519.00%
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
1.28M
+354296.00%
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Spike N. Loy, J.D.
Mr. Spike N. Loy, J.D.
Independent Director
Independent Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: 5 hours ago
마지막 업데이트: 5 hours ago
주주
주주 유형
주주
주주
비율
BVF Partners L.P.
27.88%
Deep Track Capital LP
6.51%
Santos da Silva (Jorge)
4.34%
Reich (Kristian)
4.18%
Avoro Capital Advisors LLC
2.82%
기타
54.27%
주주
주주
비율
BVF Partners L.P.
27.88%
Deep Track Capital LP
6.51%
Santos da Silva (Jorge)
4.34%
Reich (Kristian)
4.18%
Avoro Capital Advisors LLC
2.82%
기타
54.27%
주주 유형
주주
비율
Hedge Fund
47.83%
Individual Investor
10.56%
Investment Advisor
6.71%
Investment Advisor/Hedge Fund
5.77%
Research Firm
1.10%
Venture Capital
0.49%
Sovereign Wealth Fund
0.33%
Bank and Trust
0.11%
Pension Fund
0.04%
기타
27.06%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
347
43.70M
61.69%
-21.61M
2025Q3
336
52.26M
73.22%
-13.87M
2025Q2
326
71.15M
112.06%
-8.45M
2025Q1
329
71.47M
112.59%
-8.98M
2024Q4
308
74.57M
117.86%
+1.09M
2024Q3
292
73.42M
116.42%
+551.38K
2024Q2
282
72.21M
114.78%
+1.82M
2024Q1
274
70.82M
112.58%
-306.27K
2023Q4
260
64.82M
107.09%
-2.17M
2023Q3
219
60.33M
114.64%
-5.55M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BVF Partners L.P.
19.75M
27.88%
--
--
Nov 06, 2025
Deep Track Capital LP
4.61M
6.51%
+4.61M
--
Nov 05, 2025
Santos da Silva (Jorge)
3.07M
4.34%
-3.68K
-0.12%
Dec 19, 2025
Reich (Kristian)
2.96M
4.18%
-167.52K
-5.35%
Dec 19, 2025
Avoro Capital Advisors LLC
2.00M
2.82%
-2.15M
-51.81%
Sep 30, 2025
Cormorant Asset Management, LP
1.99M
2.81%
-6.50M
-76.52%
Sep 30, 2025
Balyasny Asset Management LP
1.70M
2.4%
+1.28M
+301.55%
Sep 30, 2025
Adage Capital Management, L.P.
1.50M
2.12%
+1.50M
--
Sep 30, 2025
Bodenstedt (Matthias)
922.01K
1.3%
+294.47K
+46.93%
Dec 19, 2025
Schonfeld Strategic Advisors LLC
965.40K
1.36%
+965.40K
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Tue, Dec 2
마지막 업데이트: Tue, Dec 2
이름
비율
ALPS Medical Breakthroughs ETF
0.27%
Global X Guru Index ETF
0.22%
Virtus LifeSci Biotech Clinical Trials ETF
0.16%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.02%
Strive Small-Cap ETF
0.02%
Nuveen ESG Small-Cap ETF
0.02%
iShares Morningstar Small-Cap ETF
0.01%
John Hancock Multifactor Small Cap ETF
0.01%
iShares ESG Aware MSCI USA Small-Cap ETF
0.01%
Fidelity Nasdaq Composite Index ETF
0.01%
더 보기
ALPS Medical Breakthroughs ETF
비율0.27%
Global X Guru Index ETF
비율0.22%
Virtus LifeSci Biotech Clinical Trials ETF
비율0.16%
JPMorgan BetaBuilders US Small Cap Equity ETF
비율0.02%
Strive Small-Cap ETF
비율0.02%
Nuveen ESG Small-Cap ETF
비율0.02%
iShares Morningstar Small-Cap ETF
비율0.01%
John Hancock Multifactor Small Cap ETF
비율0.01%
iShares ESG Aware MSCI USA Small-Cap ETF
비율0.01%
Fidelity Nasdaq Composite Index ETF
비율0.01%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
